GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 208 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,860,000 | -13.6% | 42,001 | -59.4% | 0.02% | -9.1% |
| Q2 2022 | $3,309,000 | +0.2% | 103,564 | +8.6% | 0.02% | +22.2% |
| Q1 2022 | $3,304,000 | +25.0% | 95,374 | +5.6% | 0.02% | +28.6% |
| Q4 2021 | $2,643,000 | +2596.9% | 90,288 | +3136.1% | 0.01% | +1300.0% |
| Q2 2021 | $98,000 | -19.7% | 2,790 | -6.7% | 0.00% | 0.0% |
| Q1 2021 | $122,000 | +662.5% | 2,991 | +724.0% | 0.00% | – |
| Q4 2020 | $16,000 | -23.8% | 363 | -6.2% | 0.00% | – |
| Q3 2020 | $21,000 | 0.0% | 387 | +14.8% | 0.00% | – |
| Q2 2020 | $21,000 | +5.0% | 337 | -52.8% | 0.00% | – |
| Q2 2017 | $20,000 | -89.5% | 714 | -87.9% | 0.00% | -100.0% |
| Q4 2015 | $191,000 | – | 5,908 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
| Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
| Grace Capital | 124,749 | $6,878,000 | 5.33% |
| Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
| Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
| ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
| Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
| Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
| Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |